GeoVax Targets 2026 as Breakout Year with Key Vaccine and Cancer Therapy Milestones
January 20, 2026 — GeoVax Labs announces 2026 as a pivotal year with milestones for Mpox/smallpox vaccine GEO-MVA, cancer therapy Gedeptin®, and COVID-19 vaccine GEO-CM04S1. Learn about regulatory progress and scalable manufacturing.